Filing Flows › Aytu Biopharma (AYTU) › R&D spending
Aytu Biopharma (AYTU) R&D spending by quarter
Aytu Biopharma's R&D spending was $216K in Q4 FY25 (fourth quarter fiscal 2025), +33% from Q3 FY25. Over the last 3 quarters it ranged from $162K (Q3 FY25) to $522K (Q2 FY25).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q4 FY25 | $216K | +33% | — |
| Q3 FY25 | $162K | -69% | — |
| Q2 FY25 | $522K | — | — |
Q4 FY25 at a glance
Aytu Biopharma, Q4 FY25: revenue $15.1M (+4% year over year), operating margin -50.4%, net loss $19.8M, operating cash flow $2.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Aytu Biopharma's R&D spending?
Aytu Biopharma's R&D spending was $216K in Q4 FY25 (fourth quarter fiscal 2025), +33% from Q3 FY25.
How has Aytu Biopharma's R&D spending changed?
Over the last 3 quarters it ranged from $162K (Q3 FY25) to $522K (Q2 FY25).